Insider Transactions in Q1 2022 at Repligen Corp (RGEN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Manner Carrie Eglinton |
BUY
Open market or private purchase
|
Direct |
625
+22.89%
|
$109,375
$175.02 P/Share
|
|
Mar 08
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+5.02%
|
$191,636
$46.7 P/Share
|
|
Mar 01
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
7,292
-3.53%
|
$1,414,648
$194.06 P/Share
|
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
SELL
Open market or private sale
|
Direct |
2,000
-34.81%
|
$396,000
$198.03 P/Share
|
|
Mar 01
2022
|
Thomas F Ryan Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+22.44%
|
$38,000
$38.76 P/Share
|
|
Feb 28
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
598
-1.71%
|
$117,208
$196.7 P/Share
|
|
Feb 28
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
16,538
-3.86%
|
$3,241,448
$196.7 P/Share
|
|
Feb 28
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
30,074
+12.03%
|
-
|
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,129
-4.23%
|
$613,284
$196.7 P/Share
|
|
Feb 28
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,922
+13.42%
|
-
|
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,057
-4.8%
|
$403,172
$196.7 P/Share
|
|
Feb 28
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,234
+15.89%
|
-
|
|
Feb 27
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.3%
|
$90,552
$196.7 P/Share
|
|
Feb 27
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,754
-1.41%
|
$539,784
$196.7 P/Share
|
|
Feb 27
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
695
-2.07%
|
$136,220
$196.7 P/Share
|
|
Feb 27
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-2.49%
|
$93,492
$196.7 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-1.83%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,366
+24.71%
|
-
|
|
Feb 24
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.51%
|
$34,209
$189.21 P/Share
|
|
Feb 24
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
2,124
+5.62%
|
-
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-0.97%
|
$35,532
$189.21 P/Share
|
|
Feb 24
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
2,126
+9.92%
|
-
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.79%
|
$50,841
$189.21 P/Share
|
|
Feb 24
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,443
+9.22%
|
-
|
|
Feb 24
2022
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-0.59%
|
$221,130
$189.21 P/Share
|
|
Feb 24
2022
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
15,855
+7.45%
|
-
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.08%
|
$60,424
$182.42 P/Share
|
|
Feb 17
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+2.84%
|
-
|
|
Feb 17
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.66%
|
$40,768
$182.42 P/Share
|
|
Feb 17
2022
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.32%
|
-
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-1.01%
|
$31,850
$182.42 P/Share
|
|
Feb 17
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
450
+2.53%
|
-
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-4.62%
|
$60,788
$182.42 P/Share
|
|
Feb 17
2022
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
900
+11.08%
|
-
|